Thermo Fisher Scientific (TMO) Q1 FY26 earnings call

Thermo Fisher Scientific delivered a strong first quarter, with performance aligning with expectations across end markets. The company successfully integrated the Clario acquisition and continued to execute its growth strategy, driven by high-impact innovation and strategic collaborations. Management raised full-year guidance, reflecting operational strength and the Clario contribution, while actively managing potential inflationary pressures.